Genetic variations and clinical spectrum of dystroglycanopathy in a large cohort of Chinese patients
- PMID: 33200426
- DOI: 10.1111/cge.13886
Genetic variations and clinical spectrum of dystroglycanopathy in a large cohort of Chinese patients
Abstract
Dystroglycanopathy is a group of muscular dystrophies with deficient glycosylation of alpha-dystroglycan (α-DG). We recruited patients from 36 tertiary academic hospitals in China. In total, 143 patients with genetically diagnosed dystroglycanopathy were enrolled. Of these, limb girdle muscular dystrophy was the most common initial diagnosis (83 patients) and Walker-Warburg syndrome was the least common (1 patient). In 143 patients, mutations in FKRP gene were the most prevalent (62 patients), followed by POMT2, POMT1 (16), POMGNT1, ISPD (14), FKTN, GMPPB, B3GALNT2, DPM3, and DAG1. Several frequent mutations were identified in FKRP, POMT1, POMGNT1, ISPD, and FKTN genes. Many of these were founder mutations. Patients with FKRP mutations tended to have milder phenotypes, while those with mutations in POMGNT1 genes had more severe phenotypes. Mental retardation was a clinical feature associated with mutations of POMT1 gene. Detailed clinical data of 83 patients followed up in Peking University First Hospital were further analyzed. Our clinical and genetic analysis of a large cohort of Chinese patients with dystroglycanopathy expanded the genotype variation and clinical spectrum of congenital muscular dystrophies.
Keywords: dystroglycanopathy; genotype constituent ratio; phenotype; population study.
© 2020 John Wiley & Sons A/S . Published by John Wiley & Sons Ltd.
Similar articles
-
Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.Brain. 2007 Oct;130(Pt 10):2725-35. doi: 10.1093/brain/awm212. Epub 2007 Sep 18. Brain. 2007. PMID: 17878207
-
POMGnT1, POMT1, and POMT2 mutations in congenital muscular dystrophies.Methods Enzymol. 2010;479:343-52. doi: 10.1016/S0076-6879(10)79019-4. Methods Enzymol. 2010. PMID: 20816175
-
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study.Neurology. 2009 May 26;72(21):1802-9. doi: 10.1212/01.wnl.0000346518.68110.60. Epub 2009 Mar 18. Neurology. 2009. PMID: 19299310
-
[Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].Brain Nerve. 2008 Oct;60(10):1159-64. Brain Nerve. 2008. PMID: 18975603 Review. Japanese.
-
Molecular genetics of the POMT1-related muscular dystrophy-dystroglycanopathies.Mutat Res Rev Mutat Res. 2018 Oct-Dec;778:45-50. doi: 10.1016/j.mrrev.2018.09.002. Epub 2018 Sep 12. Mutat Res Rev Mutat Res. 2018. PMID: 30454682 Review.
Cited by
-
DAG1 haploinsufficiency is associated with sporadic and familial isolated or pauci-symptomatic hyperCKemia.Eur J Hum Genet. 2024 Mar;32(3):342-349. doi: 10.1038/s41431-023-01516-4. Epub 2024 Jan 4. Eur J Hum Genet. 2024. PMID: 38177406 Free PMC article.
-
Malformations of Core M3 on α-Dystroglycan Are the Leading Cause of Dystroglycanopathies.J Mol Neurosci. 2025 Feb 25;75(1):28. doi: 10.1007/s12031-025-02320-z. J Mol Neurosci. 2025. PMID: 39998573 Free PMC article. Review.
-
Compound heterozygous B3GALNT2 mutations in a fetus with encephalocele: A case report.Clin Case Rep. 2024 Apr 5;12(4):e8691. doi: 10.1002/ccr3.8691. eCollection 2024 Apr. Clin Case Rep. 2024. PMID: 38585583 Free PMC article.
-
Unique genotype-phenotype correlations within LAMA2-related limb girdle muscular dystrophy in Chinese patients.Front Neurol. 2023 May 3;14:1158094. doi: 10.3389/fneur.2023.1158094. eCollection 2023. Front Neurol. 2023. PMID: 37206914 Free PMC article.
-
Expert Panel Curation of 31 Genes in Relation to Limb Girdle Muscular Dystrophy.bioRxiv [Preprint]. 2024 May 6:2024.05.03.592369. doi: 10.1101/2024.05.03.592369. bioRxiv. 2024. Update in: Ann Clin Transl Neurol. 2024 Sep;11(9):2268-2276. doi: 10.1002/acn3.52127. PMID: 38765987 Free PMC article. Updated. Preprint.
References
REFERENCES
-
- Astrea G, Romano A, Angelini C, et al. Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. Orphanet J Rare Dis. 2018;13:170.
-
- Kanagawa M, Toda T. Muscular dystrophy with ribitol-phosphate deficiency: a novel post-translational mechanism in dystroglycanopathy. J Neuromuscul Dis. 2017;4:259-267.
-
- Carss KJ, Stevens E, Foley AR, et al. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. Am J Hum Genet. 2013;93:29-34.
-
- Van den Bergh P, Sznajer Y, Van Parys V, et al. A homozygous DPM3 mutation in a patient with alpha-dystroglycan-related limb girdle muscular dystrophy. Neuromuscul Disord. 2017;27:1043-1046.
-
- Dong M, Noguchi S, Endo Y, et al. DAG1 mutations associated with asymptomatic hyperCKemia and hypoglycosylation of α-dystroglycan. Neurology. 2015;84:273-279.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous